Medicofarma Biotech Cash Flow Statement

Financials in millions PLN. Fiscal year is January - December.

Millions PLN. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Net Income	-3.06	-2.3	-3.44	-1.59	-0.22	-0.92
Depreciation & Amortization	1.55	1.55	1.99	1.75	0.95	0.04
Other Adjustments	0.14	0.14	0.89	0.05	-0.05	0.13
Change in Receivables	-0.23	-0.25	0.2	0.86	-1.29	0.49
Changes in Inventories	0	0	0.14	0.41	-0.42	0.21
Changes in Accounts Payable	0.92	1.31	0.3	-0.14	1.94	-0.23
Changes in Other Operating Activities	-0.61	-1.47	-0.07	-0.37	0.9	-0.03
Operating Cash Flow	-1.28	-1.02	0.01	0.96	1.82	-0.31
Operating Cash Flow Growth	-	-	-99.24%	-47.11%	-	-
Capital Expenditures	-	0	-1.11	-1.21	-2.3	0
Sale of Property, Plant & Equipment	-	0	0	0	0	0
Proceeds from Sale of Intangible Assets	-	0	0	0	0	0.24
Proceeds from Sale of Investments	-	0	0	0	0	0.1
Other Investing Activities	-	0	0	0	-13.71	0.1
Investing Cash Flow	-	0	-1.11	-1.21	-16.01	0.34
Long-Term Debt Issued	1.3	1.37	1.11	0.69	0	0.23
Long-Term Debt Repaid	-	-0.35	-0.51	0	-0.39	0
Net Long-Term Debt Issued (Repaid)	1.3	1.02	0.6	0.69	-0.39	0.23
Issuance of Common Stock	-	0	0	0	14.65	0
Net Common Stock Issued (Repurchased)	-	0	0	0	14.65	0
Other Financing Activities	-	0	0	-0.01	-0.01	-0.3
Financing Cash Flow	1.3	1.02	0.6	0.68	14.25	-0.07
Net Cash Flow	0.02	0	-0.5	0.43	0.05	-0.04
Free Cash Flow	-1.28	-1.02	-1.1	-0.25	-0.48	-0.31
Free Cash Flow Growth	-	-	-	-	-	-
FCF Margin	-455.80%	-83.23%	-146.38%	-5.83%	-14.48%	-8.54%
Free Cash Flow Per Share	-0.02	-0.01	-0.02	-0.00	-0.01	-0.05
Levered Free Cash Flow	0.11	0.11	-1.59	-0.46	0.47	-0.7
Unlevered Free Cash Flow	-0.95	-0.67	-2.02	-1.14	0.86	-0.62